India, Sept. 11 -- The Government of India has issued a release:
The Indian Pharmacopoeia Commission (IPC), an autonomous institution under the Ministry of Health and Family Welfare, Government of India, organized a two-day National Conference on "Quality and Safety of Biosimilars: Strengthening India's Biopharma SHAKTI Vision" on September 10-11, 2026, at the Centre for Cellular and Molecular Platforms (C-CAMP), Bengaluru. The conference was attended by 160 participants from regulatory authorities, industry, academia, research organizations and other stakeholder groups.
The conference was organized by IPC in collaboration with the Indian Drug Manufacturers' Association (IDMA), with the Biotechnology Industry Research Assistance Council (...